Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $511,754 - $692,554
15,322 Added 134.56%
26,709 $946,000
Q4 2023

Feb 14, 2024

SELL
$34.21 - $44.59 $875,194 - $1.14 Million
-25,583 Reduced 69.2%
11,387 $495,000
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $12.6 Million - $15.3 Million
-333,318 Reduced 90.02%
36,970 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$37.95 - $58.98 $14.1 Million - $21.8 Million
370,288 New
370,288 $15.2 Million
Q1 2022

May 16, 2022

SELL
$62.86 - $69.24 $255,400 - $281,322
-4,063 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $1.55 Million - $1.82 Million
-24,793 Reduced 85.92%
4,063 $272,000
Q2 2021

Aug 13, 2021

BUY
$66.79 - $76.63 $1.93 Million - $2.21 Million
28,856 New
28,856 $1.97 Million
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $545,835 - $838,729
-12,603 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$43.33 - $51.72 $546,087 - $651,827
12,603 New
12,603 $595,000
Q2 2020

Aug 13, 2020

SELL
$41.42 - $55.57 $450,939 - $604,990
-10,887 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $399,226 - $664,542
10,887 New
10,887 $486,000
Q4 2019

Feb 14, 2020

SELL
$55.73 - $62.49 $21.9 Million - $24.6 Million
-392,910 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$53.29 - $64.59 $501,245 - $607,533
-9,406 Reduced 2.34%
392,910 $23.6 Million
Q2 2019

Aug 14, 2019

BUY
$46.45 - $55.85 $9.81 Million - $11.8 Million
211,100 Added 110.4%
402,316 $22.5 Million
Q1 2019

May 14, 2019

BUY
$42.97 - $57.33 $2.05 Million - $2.74 Million
47,790 Added 33.32%
191,216 $10.7 Million
Q4 2018

Feb 14, 2019

BUY
$42.62 - $64.51 $6.11 Million - $9.25 Million
143,426 New
143,426 $6.47 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.